Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR-Mutated Elderly Pulmonary Adenocarcinoma Patients

BACKGROUND. Lung cancer is frequently a disease of elderly patients. However, these patients are often treated less actively owing to a higher comorbidity rate and poor performance status. The efficacy of different treatments in elderly patients with epidermal growth factor receptor (EGFR)-mutated l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Tseng, Yen-Han, Tseng, Yen-Chiang, Lin, Yi-hsuan, Lee, Yu-Chin, Perng, Reury-Perng, Whang-Peng, Jacqueline, Chen, Yuh-Min
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Geriatric Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492228/
https://ncbi.nlm.nih.gov/pubmed/26054633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0352
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados